Session

Liver & biliary (Posters)

EFFECT OF CHOLECYSTECTOMY ON HEPATIC STEATOSIS AND INSULIN RESISTANCE ASSESSED BY CONTROLLED ATTENUATION PARAMETER (CAP) AND MRI IN NON-ALCOHOLIC FATTY LIVER (NAFLD) ALGERIAN PATIENTS: A PILOT STUDY
EFFECT OF CHOLECYSTECTOMY ON HEPATIC STEATOSIS AND INSULIN RESISTANCE ASSESSED BY CONTROLLED ATTENUATION PARAMETER (CAP) AND MRI IN NON-ALCOHOLIC FATTY LIVER (NAFLD) ALGERIAN PATIENTS: A PILOT STUDY

DIABETES MELLITUS DOES NOT INCREASE THE RISK OF RECURRENT HEPATOCELLULAR CARCINOMA AFTER DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C: SYSTEMATIC REVIEW WITH META-ANALYSIS
DIABETES MELLITUS DOES NOT INCREASE THE RISK OF RECURRENT HEPATOCELLULAR CARCINOMA AFTER DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C: SYSTEMATIC REVIEW WITH META-ANALYSIS

RISK STRATIFICATION IN AUTOIMMUNE HEPATITIS: EARLY NORMALIZATION OF TRANSAMINASES MAY IDENTIFY PATIENTS WITH SUBOPTIMAL TREATMENT RESPONSE
RISK STRATIFICATION IN AUTOIMMUNE HEPATITIS: EARLY NORMALIZATION OF TRANSAMINASES MAY IDENTIFY PATIENTS WITH SUBOPTIMAL TREATMENT RESPONSE

CHRONIC HEPATITIS B GENOTYPE E: A REALITY IN A DISTRICT HOSPITAL IN PORTUGAL
CHRONIC HEPATITIS B GENOTYPE E: A REALITY IN A DISTRICT HOSPITAL IN PORTUGAL

DIABETES MELLITUS INCREASES THE RISK OF HEPATOCELLULAR CARCINOMA AFTER DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C: A SYSTEMATIC REVIEW WITH META-ANALYSIS
DIABETES MELLITUS INCREASES THE RISK OF HEPATOCELLULAR CARCINOMA AFTER DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C: A SYSTEMATIC REVIEW WITH META-ANALYSIS

ELIMINATION OF HEPATITIS C BASED ON FOCUS PROGRAM
ELIMINATION OF HEPATITIS C BASED ON FOCUS PROGRAM

HEMORRHAGIC ASCITES: A POOR PROGNOSTIC MARKER IN DECOMPENSATED LIVER CIRRHOSIS
HEMORRHAGIC ASCITES: A POOR PROGNOSTIC MARKER IN DECOMPENSATED LIVER CIRRHOSIS

VITAMIN D DEFICIENCY IS ASSOCIATED WITH SIGNIFICANT STEATOSIS, ADVANCED FIBROSIS AND NON-ALCOHOLIC STEATOHEPATITIS (NASH), IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
VITAMIN D DEFICIENCY IS ASSOCIATED WITH SIGNIFICANT STEATOSIS, ADVANCED FIBROSIS AND NON-ALCOHOLIC STEATOHEPATITIS (NASH), IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

PREVALENCE OF PERIODONTAL DISEASE IN PATIENTS WITH LIVER CIRRHOSIS AND ITS INFLUENCE ON THE SHORT-TERM OUTCOME OF THE DISEASE
PREVALENCE OF PERIODONTAL DISEASE IN PATIENTS WITH LIVER CIRRHOSIS AND ITS INFLUENCE ON THE SHORT-TERM OUTCOME OF THE DISEASE

METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) - RATHER A BYSTANDER THAN A DRIVER OF MORTALITY
METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) - RATHER A BYSTANDER THAN A DRIVER OF MORTALITY

INTERLEUKIN GENES ASSOCIATED WITH THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AS A RESULT OF VIRAL HEPATITIS B AND C
INTERLEUKIN GENES ASSOCIATED WITH THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AS A RESULT OF VIRAL HEPATITIS B AND C

VALUE OF HITACHI SHEAR WAVE ELASTOGRAPHY (SWE) TO RULE-IN AND RULE-OUT THE PRESENCE OF ESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED LIVER DISEASE
VALUE OF HITACHI SHEAR WAVE ELASTOGRAPHY (SWE) TO RULE-IN AND RULE-OUT THE PRESENCE OF ESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED LIVER DISEASE

PREDICTIVE FACTORS FOR SUSTAINED COMPLETE RESPONSE AFTER TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
PREDICTIVE FACTORS FOR SUSTAINED COMPLETE RESPONSE AFTER TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

FIRST REPORT OF V-SET AND IMMUNOGLOBULIN DOMAIN CONTAINING 1 EXPRESSION IN HEPATOCELLULAR CARCINOMA
FIRST REPORT OF V-SET AND IMMUNOGLOBULIN DOMAIN CONTAINING 1 EXPRESSION IN HEPATOCELLULAR CARCINOMA

THE IMPACT OF THE COVID 19 PANDEMIC ON HEPATOCELLULAR CARCINOMA SCREENING IN PATIENTS WITH CIRRHOSIS
THE IMPACT OF THE COVID 19 PANDEMIC ON HEPATOCELLULAR CARCINOMA SCREENING IN PATIENTS WITH CIRRHOSIS

A DEEP LEARNING-BASED SYSTEM FOR PREDICTING THE RISK OF HEMORRHAGE OF GASTROESOPHAGEAL VARICES QUANTITATIVELY UNDER ENDOSCOPY
A DEEP LEARNING-BASED SYSTEM FOR PREDICTING THE RISK OF HEMORRHAGE OF GASTROESOPHAGEAL VARICES QUANTITATIVELY UNDER ENDOSCOPY

LOW INTERQUARTILE RANGE OF LIVER STIFFNESS MEASUREMENT IS INDEPENDENTLY ASSOCIATED WITH 30-DAY MORTALITY AMONG HOSPITALIZED NON-CRITICALLY ILL PATIENTS WITH COVID-19
LOW INTERQUARTILE RANGE OF LIVER STIFFNESS MEASUREMENT IS INDEPENDENTLY ASSOCIATED WITH 30-DAY MORTALITY AMONG HOSPITALIZED NON-CRITICALLY ILL PATIENTS WITH COVID-19

DIAGNOSTIC ACCURACY OF DIGITAL SINGLE-OPERATOR CHOLANGIOSCOPY FOR INDETERMINATE BILIARY STRICTURE: AN ITALIAN SINGLE-CENTER EXPERIENCE
DIAGNOSTIC ACCURACY OF DIGITAL SINGLE-OPERATOR CHOLANGIOSCOPY FOR INDETERMINATE BILIARY STRICTURE: AN ITALIAN SINGLE-CENTER EXPERIENCE

THE LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS AFTER CHOLECYSTECTOMY
THE LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS AFTER CHOLECYSTECTOMY

THE SPECTRUM OF DECOMPENSATED CIRRHOSIS: WHICH SCORES PERFORM THE BEST IN PREDICTING MORTALITY?
THE SPECTRUM OF DECOMPENSATED CIRRHOSIS: WHICH SCORES PERFORM THE BEST IN PREDICTING MORTALITY?

Item 21 - 40 / 270
1
2
3 4 5 6 7 8 9 10 11 12 13 14